TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/29/23 16:20 | 12/27/23 | ALPN | Alpine Immune Sciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Thompson Peter A. | WA | D | S.m | -28,672 | 18.54 | 0 | -1,546 | -85 | 264 | I | |||||||||||||||
12/30/21 20:55 | 12/29/21 | JANX | Janux Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Thompson Peter A. | CA | D | S | -820 | 20.30 | 0 | -40 | -15 | 231 | I | |||||||||||||||
12/23/21 16:08 | 12/21/21 | JANX | Janux Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Thompson Peter A. | CA | D | S | -2,269 | 19.00 | 0 | -119 | -34 | 235 | I | |||||||||||||||
12/17/21 17:16 | 12/16/21 | JANX | Janux Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Thompson Peter A. | CA | D | S | -7,500 | 19.07 | 0 | -393 | -62 | 246 | I | |||||||||||||||
9/22/21 17:24 | 9/20/21 | CRVS | Corvus Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Thompson Peter A. | CA | DT | S | -6,758 | 6.09 | 0 | -1,110 | -14 | 6,944 | I |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |